BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37876819)

  • 1. WIP1 is a novel specific target for growth hormone action.
    Apaydin T; Zonis S; Zhou C; Valencia CW; Barrett R; Strous GJ; Mol JA; Chesnokova V; Melmed S
    iScience; 2023 Nov; 26(11):108117. PubMed ID: 37876819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis.
    Yang YQ; Zheng YH; Zhang CT; Liang WW; Wang SY; Wang XD; Wang Y; Wang TH; Jiang HQ; Feng HL
    Neurobiol Dis; 2020 Feb; 134():104648. PubMed ID: 31676238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
    Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
    Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess growth hormone suppresses DNA damage repair in epithelial cells.
    Chesnokova V; Zonis S; Barrett R; Kameda H; Wawrowsky K; Ben-Shlomo A; Yamamoto M; Gleeson J; Bresee C; Gorbunova V; Melmed S
    JCI Insight; 2019 Feb; 4(3):. PubMed ID: 30728323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Hormone Induces Colon DNA Damage Independent of IGF-1.
    Chesnokova V; Zonis S; Barrett RJ; Gleeson JP; Melmed S
    Endocrinology; 2019 Jun; 160(6):1439-1447. PubMed ID: 31002310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
    Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
    Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage.
    Dayaram T; Lemoine FJ; Donehower LA; Marriott SJ
    PLoS One; 2013; 8(2):e55989. PubMed ID: 23405243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local non-pituitary growth hormone is induced with aging and facilitates epithelial damage.
    Chesnokova V; Zonis S; Apostolou A; Estrada HQ; Knott S; Wawrowsky K; Michelsen K; Ben-Shlomo A; Barrett R; Gorbunova V; Karalis K; Melmed S
    Cell Rep; 2021 Dec; 37(11):110068. PubMed ID: 34910915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.
    Macurek L; Benada J; Müllers E; Halim VA; Krejčíková K; Burdová K; Pecháčková S; Hodný Z; Lindqvist A; Medema RH; Bartek J
    Cell Cycle; 2013 Jan; 12(2):251-62. PubMed ID: 23255129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
    Storchova R; Burdova K; Palek M; Medema RH; Macurek L
    FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIP1 dephosphorylation of p27
    Choi BK; Fujiwara K; Dayaram T; Darlington Y; Dickerson J; Goodell MA; Donehower LA
    Cell Cycle; 2020 Feb; 19(4):479-491. PubMed ID: 31959038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication.
    Sakai H; Fujigaki H; Mazur SJ; Appella E
    Cell Cycle; 2014; 13(6):1015-29. PubMed ID: 24552809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic WIP1 phosphatase attenuates the DNA damage response and sensitizes p53 mutant Jurkat cells to apoptosis.
    Eren MK; Kartal NB; Pilevneli H
    Oncol Lett; 2021 Jun; 21(6):479. PubMed ID: 33968195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
    Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
    Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms.
    Jonak K; Kurpas M; Szoltysek K; Janus P; Abramowicz A; Puszynski K
    BMC Syst Biol; 2016 Aug; 10(1):75. PubMed ID: 27526774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
    Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
    Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH and Senescence: A New Understanding of Adult GH Action.
    Chesnokova V; Melmed S
    J Endocr Soc; 2022 Jan; 6(1):bvab177. PubMed ID: 34909519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.
    Lu X; Nguyen TA; Moon SH; Darlington Y; Sommer M; Donehower LA
    Cancer Metastasis Rev; 2008 Jun; 27(2):123-35. PubMed ID: 18265945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.